The Lancet. Respiratory medicine
Journal
Overview
publication venue for
-
Use of lung-cancer trends for global and public health priorities..
13.
2025
-
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
2024
-
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study..
11.
2023
-
Smoking and e-cigarette use: key variables in testing IgA-oriented intranasal vaccines..
10.
2022
-
Moving beyond usual interstitial pneumonia to define progressive fibrotic interstitial lung disease..
9.
2021
-
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial..
9.
2020
-
Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study..
8.
2019
-
The gender gap in critical care task force participation..
7.
2019
-
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)..
6.
2018
-
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial..
6.
2018
-
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort..
5.
2017
-
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study..
5.
2017
-
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study..
5.
2017
-
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial..
5.
2016
-
Molecular mechanisms underlying variations in lung function: a systems genetics analysis..
3.
2015
-
Intensive care unit provision at the end of life: miles travelled, miles to go..
7.
2019
-
Serum procalcitonin and the admission decision in CAP..
4.
2016
-
Targeted therapy outcomes in RET-rearranged lung cancers: drug or driver?.
5.
2016
-
Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples.
2021
-
Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency.
2016
-
Community-acquired pneumonia: the best candidates for clarithromycin - Authors' reply.
2024
-
Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply.
2018
-
COPD and multimorbidity: recognising and addressing a syndemic occurrence.
2023
-
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?
2020
-
Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data.
2016
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)